Our Business
Meldex International is a specialty pharmaceutical and healthcare business that uses its XGEL™ polymer technology to develop and enhance its pharmaceutical and healthcare products and those of its partners.
Operating Companies
The Meldex International new company name is formed from our OTC division, Melbrosin, and Dexo Pharma, our RX division.
Find out more
Published : 29/11/2007 10:48:02
Latest News
28.08.08
Meldex releases further details of the Company’s exciting novel topical analgesic (benzocaine)
Find out more...
22.08.08
Meldex releases further details of the Company’s exciting SoluPol development and line extension to
Find out more...
12.08.08
Meldex releases further details of the Company’s exciting novel anti-emetic (granisetron) OradiscTM
Find out more...
Delayed Share Price
Mid Price: 27.50p
Change: -0.50p
(-1.79%
)
Bid:
27.25p
Ask:
27.75p
Last Trade: 27.75p
Last Close: 28.00p
Data delayed at least 15 minutes
Meldex Internationl Plc trade on the LSE:AIM. (Symbol: MDX)
view further share info...